Das klingt doch super.
"The third expected EUA is from CytoDyn Inc. (OTCMKTS: CYDY). This is a repurposed monoclonal antibody that is the only remaining phase 3 drug candidate with a mortality benefit that has not had to resize its study after meeting an interim checkpoint. This drug has a stellar safety profile with over a thousand patients and no SAE’s related to the drug. It is an anomaly because leronlimab showed it actually reduced the side effects over placebo by as much as 60% in a phase 2 mild to moderate study. Now that’s a safe drug! The company is hosting an investor update on Thursday December 10, 2020 and may be close to finishing its trial. "
Morgen mal reinhören !
Investment Community Webcast
Dec 10, 2020 • 1:00 pm PST
Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Thursday, December 10, 2020.
Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities.
Management will also provide approximately 30-45 minutes to address questions submitted online by analysts and investors.
Date: Thursday, December 10, 2020
Time: 1:00 pm PT / 4:00 pm ET
Dial-In: None.
Questions:
Prior to the webcast, questions can be submitted online to CYDY_Team@cytodyn.com
During the webcast, questions can be submitted through the webcast link below.
This is a “listen only” webcast, which can be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 30 days. Participants are encouraged to go to the website 15 minutes prior to the start of the webcast to register, download and install any necessary software. The webcast can also be accessed via the following link:
78449.themediaframe.com/dataconf/...iaframe/42454/indexl.html
The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until January 10, 2021.
www.cytodyn.com/investors/news-events/...nt-community-webcast
Zurück
